SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3t6q'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DDS_B_MTXB201_1
(DIHYDROFOLATE
REDUCTASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 ALA A 551
LYS A 598
SER A 536
ILE A 537
LEU A 566
 None
GOL  A   9 (-3.2A)
None
None
None
 1.15A 1ddsB-3t6qA:
undetectable		 1ddsB-3t6qA:
14.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DZM_A_BZMA600_0
(ODORANT-BINDING
PROTEIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 8 ILE A 238
ASN A 207
ASN A 228
LEU A 188
 None
 1.00A 1dzmA-3t6qA:
undetectable		 1dzmA-3t6qA:
14.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ICU_B_NIOB219_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 PHE A  81
GLU A  40
SER A  61
THR A  85
 None
 1.15A 1icuA-3t6qA:
undetectable
1icuB-3t6qA:
undetectable		 1icuA-3t6qA:
15.55
1icuB-3t6qA:
15.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ICU_C_NIOC225_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 SER A  61
THR A  85
PHE A  81
GLU A  40
 None
 1.16A 1icuC-3t6qA:
undetectable
1icuD-3t6qA:
undetectable		 1icuC-3t6qA:
15.55
1icuD-3t6qA:
15.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IG3_A_VIBA502_1
(THIAMIN
PYROPHOSPHOKINASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 8 LEU A 519
SER A 460
ASN A 490
GLN A 463
 None
 1.00A 1ig3A-3t6qA:
undetectable
1ig3B-3t6qA:
undetectable		 1ig3A-3t6qA:
16.78
1ig3B-3t6qA:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IG3_B_VIBB501_1
(THIAMIN
PYROPHOSPHOKINASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 GLN A 463
LEU A 519
SER A 460
ASN A 490
 None
 1.16A 1ig3A-3t6qA:
undetectable
1ig3B-3t6qA:
undetectable		 1ig3A-3t6qA:
16.78
1ig3B-3t6qA:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KQB_C_BEZC522_0
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 SER A  61
THR A  85
PHE A  81
GLU A  40
 None
 1.17A 1kqbC-3t6qA:
undetectable
1kqbD-3t6qA:
undetectable		 1kqbC-3t6qA:
16.17
1kqbD-3t6qA:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OSV_B_CHCB201_1
(BILE ACID RECEPTOR)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 LEU A 196
MET A 193
SER A 163
ILE A 185
PHE A 180
 GOL  A   3 (-3.6A)
None
None
None
None
 1.49A 1osvB-3t6qA:
undetectable		 1osvB-3t6qA:
17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q23_A_FUAA702_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 THR A 135
LEU A 106
PHE A  73
ALA A 117
ALA A 120
 None
 1.21A 1q23A-3t6qA:
undetectable
1q23B-3t6qA:
undetectable		 1q23A-3t6qA:
16.92
1q23B-3t6qA:
16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_C_SAMC803_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus;
Mus
musculus) 		4 / 6 ASP C 105
ASP A 376
ASN A 402
GLU C 147
 None
NAG  A 801 ( 4.2A)
NAG  A 801 (-1.8A)
None
 0.84A 1rjdC-3t6qC:
undetectable		 1rjdC-3t6qC:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TW4_A_CHDA131_0
(FATTY ACID-BINDING
PROTEIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 11 LEU A  58
ILE A  89
LEU A  65
THR A  96
PHE A  73
 None
 1.47A 1tw4A-3t6qA:
undetectable		 1tw4A-3t6qA:
10.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V55_J_CHDJ3060_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE I
CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.83A 1v55A-3t6qA:
undetectable
1v55J-3t6qA:
undetectable		 1v55A-3t6qA:
19.07
1v55J-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WRL_F_TFPF211_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 LEU A 206
PHE A 224
PHE A 219
SER A 194
 None
GOL  A   3 (-4.2A)
None
None
 1.00A 1wrlE-3t6qA:
undetectable
1wrlF-3t6qA:
undetectable		 1wrlE-3t6qA:
9.64
1wrlF-3t6qA:
9.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XWF_A_ADNA433_2
(ADENOSYLHOMOCYSTEINA
SE)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		3 / 3 THR A 306
GLU C 103
HIS A 379
 None
MAN  A 806 (-3.0A)
MAN  A 806 ( 4.0A)
 0.88A 1xwfA-3t6qA:
undetectable		 1xwfA-3t6qA:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XWF_B_ADNB433_2
(ADENOSYLHOMOCYSTEINA
SE)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		3 / 3 THR A 306
GLU C 103
HIS A 379
 None
MAN  A 806 (-3.0A)
MAN  A 806 ( 4.0A)
 0.85A 1xwfB-3t6qA:
undetectable		 1xwfB-3t6qA:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XWF_C_ADNC433_2
(ADENOSYLHOMOCYSTEINA
SE)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		3 / 3 THR A 306
GLU C 103
HIS A 379
 None
MAN  A 806 (-3.0A)
MAN  A 806 ( 4.0A)
 0.88A 1xwfC-3t6qA:
undetectable		 1xwfC-3t6qA:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XWF_D_ADND433_2
(ADENOSYLHOMOCYSTEINA
SE)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		3 / 3 THR A 306
GLU C 103
HIS A 379
 None
MAN  A 806 (-3.0A)
MAN  A 806 ( 4.0A)
 0.83A 1xwfD-3t6qA:
undetectable		 1xwfD-3t6qA:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Y0X_X_T44X500_1
(THYROID HORMONE
RECEPTOR BETA-1)		 3t6q LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		5 / 12 ALA C  32
LEU C  83
ILE C  85
PHE C  70
PHE C  51
 None
 1.40A 1y0xX-3t6qC:
undetectable		 1y0xX-3t6qC:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z95_A_198A501_2
(ANDROGEN RECEPTOR)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 LEU A  44
ASN A  45
LEU A  84
ILE A  89
 None
 0.90A 1z95A-3t6qA:
undetectable		 1z95A-3t6qA:
16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z95_A_198A501_2
(ANDROGEN RECEPTOR)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 LEU A  51
LEU A  84
LEU A  44
ILE A  68
 None
 0.93A 1z95A-3t6qA:
undetectable		 1z95A-3t6qA:
16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z95_A_198A501_2
(ANDROGEN RECEPTOR)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 LEU A 457
ASN A 479
LEU A 501
LEU A 450
 None
 1.02A 1z95A-3t6qA:
undetectable		 1z95A-3t6qA:
16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BFP_A_H4BA1290_1
(PTERIDINE REDUCTASE
1)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 8 PHE A 344
LEU A 317
LEU A 310
LEU A 305
 None
 1.05A 2bfpA-3t6qA:
undetectable		 2bfpA-3t6qA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BFP_B_H4BB1290_1
(PTERIDINE REDUCTASE
1)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 8 PHE A 344
LEU A 317
LEU A 310
LEU A 305
 None
 1.00A 2bfpB-3t6qA:
undetectable		 2bfpB-3t6qA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXE_B_1FLB2003_1
(SERUM ALBUMIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 10 LEU A 113
LEU A 108
LEU A 130
ILE A 143
ALA A 120
 None
 1.14A 2bxeB-3t6qA:
undetectable		 2bxeB-3t6qA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JAP_A_J01A1249_1
(CLAVALDEHYDE
DEHYDROGENASE)		 3t6q LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		5 / 12 ILE C  55
ALA C  32
VAL C 159
ALA C 157
TYR C  42
 None
 1.16A 2japA-3t6qC:
undetectable		 2japA-3t6qC:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JAP_C_J01C1249_1
(CLAVALDEHYDE
DEHYDROGENASE)		 3t6q LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		5 / 12 ILE C  55
ALA C  32
VAL C 159
ALA C 157
TYR C  42
 None
 1.16A 2japC-3t6qC:
undetectable		 2japC-3t6qC:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_A_AG2A671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A  92
GLN A 100
LEU A  82
LEU A  65
 None
 1.01A 2qqcB-3t6qA:
undetectable
2qqcC-3t6qA:
undetectable		 2qqcB-3t6qA:
10.44
2qqcC-3t6qA:
6.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_A_AG2A672_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 LEU A  82
LEU A  65
ILE A  92
GLN A 100
 None
 0.98A 2qqcA-3t6qA:
undetectable
2qqcF-3t6qA:
undetectable		 2qqcA-3t6qA:
6.44
2qqcF-3t6qA:
10.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_I_AG2I671_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 LEU A  82
LEU A  65
ILE A  92
GLN A 100
 None
 1.01A 2qqcG-3t6qA:
undetectable
2qqcJ-3t6qA:
undetectable		 2qqcG-3t6qA:
6.44
2qqcJ-3t6qA:
10.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QQC_I_AG2I672_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE (EC
4.1.1.19) (PVLARGDC))		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 LEU A  82
LEU A  65
ILE A  92
GLN A 100
 None
 1.02A 2qqcI-3t6qA:
undetectable
2qqcL-3t6qA:
undetectable		 2qqcI-3t6qA:
6.44
2qqcL-3t6qA:
10.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 PHE A 239
LEU A 281
PHE A 297
GLY A 253
 None
 1.01A 2v0mC-3t6qA:
undetectable		 2v0mC-3t6qA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VDY_A_HCYA1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 SER A 535
GLN A 493
ILE A 486
ASN A 485
PHE A 516
 None
 1.39A 2vdyA-3t6qA:
undetectable		 2vdyA-3t6qA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YOE_C_FL7C1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		4 / 8 ASN A 205
GLY A 208
ASN A 207
ILE C  78
 GOL  C  12 ( 4.9A)
None
None
None
 0.88A 2yoeB-3t6qA:
undetectable
2yoeC-3t6qA:
undetectable		 2yoeB-3t6qA:
19.14
2yoeC-3t6qA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG3_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.87A 3ag3A-3t6qA:
undetectable
3ag3J-3t6qA:
undetectable		 3ag3A-3t6qA:
19.07
3ag3J-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG3_W_CHDW1059_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 8 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.86A 3ag3N-3t6qA:
undetectable
3ag3W-3t6qA:
undetectable		 3ag3N-3t6qA:
19.07
3ag3W-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AIA_A_SAMA206_0
(UPF0217 PROTEIN
MJ1640)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 LEU A 206
GLY A 208
LEU A 204
SER A 203
 None
 0.91A 3aiaA-3t6qA:
undetectable		 3aiaA-3t6qA:
16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AOB_C_RFPC2002_1
(ACRIFLAVINE
RESISTANCE PROTEIN B)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 MET A 116
PHE A  97
THR A 119
PHE A 132
LEU A 151
 None
 1.48A 3aobC-3t6qA:
undetectable		 3aobC-3t6qA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BGD_A_PM6A302_1
(THIOPURINE
S-METHYLTRANSFERASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 THR A  72
GLN A 100
LEU A  84
LEU A  82
 None
 1.16A 3bgdA-3t6qA:
undetectable		 3bgdA-3t6qA:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BGD_A_PM6A302_1
(THIOPURINE
S-METHYLTRANSFERASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 THR A  96
GLN A 100
LEU A  84
LEU A  82
 None
 1.00A 3bgdA-3t6qA:
undetectable		 3bgdA-3t6qA:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BGD_B_PM6B302_1
(THIOPURINE
S-METHYLTRANSFERASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 THR A  96
GLN A 100
LEU A 106
LEU A  84
 None
 0.72A 3bgdB-3t6qA:
undetectable		 3bgdB-3t6qA:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM0_B_CHDB151_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		6 / 12 ILE A 185
ILE A 211
VAL A 237
LYS A 240
GLY A 241
LEU A 204
 None
 1.38A 3em0B-3t6qA:
undetectable		 3em0B-3t6qA:
12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_K_TFPK202_1
(PROTEIN S100-A4)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 LEU A 271
ILE A 279
LEU A 300
PHE A 286
SER A 290
 None
 0.85A 3ko0K-3t6qA:
undetectable
3ko0L-3t6qA:
undetectable
3ko0S-3t6qA:
undetectable
3ko0T-3t6qA:
undetectable		 3ko0K-3t6qA:
10.23
3ko0L-3t6qA:
10.23
3ko0S-3t6qA:
10.23
3ko0T-3t6qA:
10.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KP6_B_SALB3004_1
(TRANSCRIPTIONAL
REGULATOR TCAR)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 5 ILE A  47
PHE A  60
ASP A  83
GLU A  59
 None
 1.16A 3kp6A-3t6qA:
undetectable
3kp6B-3t6qA:
undetectable		 3kp6A-3t6qA:
12.83
3kp6B-3t6qA:
12.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSL_A_PZIA802_0
(GLUTAMATE RECEPTOR 2)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		3 / 3 ASP A 380
ASN A 406
SER A 329
 None
 0.87A 3lslA-3t6qA:
undetectable
3lslD-3t6qA:
undetectable		 3lslA-3t6qA:
17.83
3lslD-3t6qA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LSL_D_PZID802_0
(GLUTAMATE RECEPTOR 2)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		3 / 3 SER A 329
ASP A 380
ASN A 406
 None
 0.88A 3lslA-3t6qA:
undetectable
3lslD-3t6qA:
undetectable		 3lslA-3t6qA:
17.83
3lslD-3t6qA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3M0W_C_P77C203_1
(PROTEIN S100-A4)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		5 / 10 SER A 158
ILE C 120
GLU C 118
LEU C  74
ASP C  77
 None
None
GOL  C  12 ( 4.9A)
None
GOL  C   4 ( 4.1A)
 1.48A 3m0wC-3t6qA:
undetectable
3m0wD-3t6qA:
undetectable
3m0wE-3t6qA:
undetectable
3m0wF-3t6qA:
undetectable		 3m0wC-3t6qA:
11.99
3m0wD-3t6qA:
11.99
3m0wE-3t6qA:
11.99
3m0wF-3t6qA:
11.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P2K_A_SAMA6735_1
(16S RRNA METHYLASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		3 / 3 ASP A 526
GLU A 600
SER A 453
 None
 0.83A 3p2kA-3t6qA:
2.0		 3p2kA-3t6qA:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P2K_C_SAMC6735_1
(16S RRNA METHYLASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 5 ASN A 451
ASP A 526
GLU A 600
SER A 453
 NAG  A 901 (-2.4A)
None
None
None
 1.00A 3p2kC-3t6qA:
undetectable		 3p2kC-3t6qA:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QT0_A_486A4_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 SER A 528
ALA A 551
TYR A 547
LEU A 548
ILE A 511
 None
 1.40A 3qt0A-3t6qA:
undetectable		 3qt0A-3t6qA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_C_9PLC501_1
(CYTOCHROME P450 2A6)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 9 PHE A 268
PHE A 239
PHE A 286
THR A 308
PHE A 294
 None
 1.39A 3t3rC-3t6qA:
undetectable		 3t3rC-3t6qA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UVV_A_T3A501_1
(THYROID HORMONE
RECEPTOR ALPHA)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 ILE A 546
ALA A 539
LEU A 527
LEU A 503
ILE A 511
 None
 0.84A 3uvvA-3t6qA:
undetectable		 3uvvA-3t6qA:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V7P_A_BEZA430_0
(AMIDOHYDROLASE
FAMILY PROTEIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 GLY A 253
PHE A 268
PHE A 239
LEU A 235
 None
 0.68A 3v7pA-3t6qA:
undetectable		 3v7pA-3t6qA:
24.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C49_B_HCYB1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 SER A 535
GLN A 493
ILE A 486
ASN A 485
PHE A 516
 None
 1.29A 4c49B-3t6qA:
undetectable		 4c49B-3t6qA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C49_C_HCYC1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 SER A 535
GLN A 493
ILE A 486
ASN A 485
PHE A 516
 None
 1.29A 4c49C-3t6qA:
undetectable		 4c49C-3t6qA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C49_D_HCYD1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 SER A 535
GLN A 493
ILE A 486
ASN A 485
PHE A 516
 None
 1.34A 4c49D-3t6qA:
undetectable		 4c49D-3t6qA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C49_D_HCYD1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 THR A 517
ILE A 486
ASN A 485
PHE A 516
HIS A 514
 None
 1.36A 4c49D-3t6qA:
undetectable		 4c49D-3t6qA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_B_NCTB501_1
(CYTOCHROME P450 2A13)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 8 PHE A 481
ALA A 515
LEU A 527
LEU A 508
 None
 0.84A 4ejgB-3t6qA:
undetectable		 4ejgB-3t6qA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_C_NCTC501_1
(CYTOCHROME P450 2A13)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 PHE A 481
ALA A 515
LEU A 527
LEU A 508
 None
 0.87A 4ejgC-3t6qA:
undetectable		 4ejgC-3t6qA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J7X_A_SASA806_1
(SEPIAPTERIN
REDUCTASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 SER A 491
LEU A 492
PHE A 481
ASP A 507
GLY A 478
 None
 1.32A 4j7xA-3t6qA:
undetectable		 4j7xA-3t6qA:
19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LRH_A_FOLA301_1
(FOLATE RECEPTOR
ALPHA)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		3 / 3 ASP A 141
TRP A  91
SER A 138
 None
 1.06A 4lrhA-3t6qA:
undetectable		 4lrhA-3t6qA:
15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MMC_A_29JA604_1
(TRANSPORTER)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A  68
PHE A  97
LEU A  84
THR A 135
 None
 0.99A 4mmcA-3t6qA:
undetectable		 4mmcA-3t6qA:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OK1_A_198A1001_2
(ANDROGEN RECEPTOR)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 8 LEU A  84
ASN A 111
HIS A  93
ILE A 114
 None
 0.86A 4ok1A-3t6qA:
undetectable		 4ok1A-3t6qA:
16.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QYN_B_RTLB201_0
(RETINOL-BINDING
PROTEIN 2)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 PHE A 224
THR A 232
LEU A 188
LEU A 250
LEU A 242
 GOL  A   3 (-4.2A)
None
None
None
None
 1.38A 4qynB-3t6qA:
undetectable		 4qynB-3t6qA:
11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X1I_B_LOCB502_2
(TUBULIN BETA CHAIN)		 3t6q LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		5 / 12 LEU C  53
LEU C 142
ALA C 157
VAL C  40
ALA C  32
 None
 1.20A 4x1iB-3t6qC:
undetectable		 4x1iB-3t6qC:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X1I_D_LOCD502_1
(TUBULIN BETA CHAIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 LEU A 377
LEU A 395
LEU A 350
ALA A 341
ILE A 339
 None
 1.02A 4x1iD-3t6qA:
undetectable		 4x1iD-3t6qA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X1Y_D_LOCD502_2
(TUBULIN BETA CHAIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 LEU A 377
LEU A 395
LEU A 350
ALA A 341
ILE A 339
 None
 1.01A 4x1yD-3t6qA:
undetectable		 4x1yD-3t6qA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X20_D_LOCD502_2
(TUBULIN BETA CHAIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 11 LEU A 377
LEU A 395
LEU A 350
ALA A 341
ILE A 339
 None
 0.98A 4x20D-3t6qA:
undetectable		 4x20D-3t6qA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XP9_C_1WEC706_1
(TRANSPORTER)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus) 		4 / 4 PHE A  62
ASP A  83
GLY C 117
SER A  61
 None
 1.19A 4xp9C-3t6qA:
undetectable		 4xp9C-3t6qA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B1A_J_CHDJ102_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.88A 5b1aA-3t6qA:
undetectable
5b1aJ-3t6qA:
undetectable		 5b1aA-3t6qA:
19.07
5b1aJ-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B3S_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.92A 5b3sA-3t6qA:
undetectable
5b3sJ-3t6qA:
undetectable		 5b3sA-3t6qA:
19.07
5b3sJ-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ITZ_B_LOCB502_1
(TUBULIN BETA-2B
CHAIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 LEU A 377
LEU A 395
LEU A 350
ALA A 341
ILE A 339
 None
 1.03A 5itzB-3t6qA:
undetectable		 5itzB-3t6qA:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J4N_A_AG2A501_1
(ARGININE/AGMATINE
ANTIPORTER)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 SER A 245
GLY A 270
MET A 274
ILE A 214
 None
 1.01A 5j4nA-3t6qA:
undetectable		 5j4nA-3t6qA:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUE_A_VIVA302_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 ILE A 247
LEU A 271
VAL A 276
ILE A 279
PHE A 286
 None
 0.96A 5mueA-3t6qA:
undetectable		 5mueA-3t6qA:
17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUG_A_VIVA301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 ILE A 247
LEU A 271
VAL A 276
ILE A 279
PHE A 286
 None
 0.92A 5mugA-3t6qA:
undetectable		 5mugA-3t6qA:
17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ODC_A_ACTA703_0
(HETERODISULFIDE
REDUCTASE, SUBUNIT A)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus;
Mus
musculus) 		4 / 4 GLN C 119
GLN A 134
PRO A 112
ALA A 110
 None
 1.48A 5odcA-3t6qC:
undetectable
5odcG-3t6qC:
undetectable		 5odcA-3t6qC:
12.15
5odcG-3t6qC:
12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ODC_G_ACTG704_0
(HETERODISULFIDE
REDUCTASE, SUBUNIT A)		 3t6q CD180 ANTIGEN
LYMPHOCYTE ANTIGEN
86
(Mus
musculus;
Mus
musculus) 		4 / 5 PRO A 112
ALA A 110
GLN C 119
GLN A 134
 None
 1.48A 5odcA-3t6qA:
undetectable
5odcG-3t6qA:
undetectable		 5odcA-3t6qA:
20.90
5odcG-3t6qA:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5SYF_B_TA1B502_1
(TUBULIN BETA CHAIN)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		5 / 12 VAL A 621
ASP A 620
GLN A 597
ARG A 617
LEU A 599
 None
 1.32A 5syfB-3t6qA:
undetectable		 5syfB-3t6qA:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDQ_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.90A 5xdqN-3t6qA:
undetectable
5xdqW-3t6qA:
undetectable		 5xdqN-3t6qA:
19.07
5xdqW-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDX_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT VIIA-HEART)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.91A 5xdxA-3t6qA:
undetectable
5xdxJ-3t6qA:
undetectable		 5xdxA-3t6qA:
19.07
5xdxJ-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZCQ_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.92A 5zcqA-3t6qA:
undetectable
5zcqJ-3t6qA:
undetectable		 5zcqA-3t6qA:
19.07
5zcqJ-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F6J_D_ACTD404_0
(L-LYSINE
3-HYDROXYLASE)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 GLN A 282
GLU A 256
HIS A 309
ALA A 307
 None
 1.13A 6f6jC-3t6qA:
undetectable
6f6jD-3t6qA:
undetectable		 6f6jC-3t6qA:
20.29
6f6jD-3t6qA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F88_A_STRA502_1
(CYTOCHROME P450
CYP260A1)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 PHE A  97
LEU A 121
ALA A 120
ASN A 111
 None
 0.95A 6f88A-3t6qA:
undetectable		 6f88A-3t6qA:
8.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F88_A_STRA502_1
(CYTOCHROME P450
CYP260A1)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 6 PHE A  97
LEU A 121
ALA A 120
THR A 135
 None
 0.96A 6f88A-3t6qA:
undetectable		 6f88A-3t6qA:
8.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NMP_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 7 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.81A 6nmpA-3t6qA:
undetectable
6nmpJ-3t6qA:
undetectable		 6nmpA-3t6qA:
19.07
6nmpJ-3t6qA:
7.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NMP_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 3t6q CD180 ANTIGEN
(Mus
musculus) 		4 / 5 ILE A 352
LEU A 377
THR A 348
LEU A 372
 None
 0.80A 6nmpN-3t6qA:
undetectable
6nmpW-3t6qA:
undetectable		 6nmpN-3t6qA:
19.07
6nmpW-3t6qA:
7.06